MB02: Clinical Trials

4 trials of MB02, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 active not recruiting, 1 completed, 1 recruiting, 1 withdrawn. 4 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 14Active not recruiting 1, Completed 1, Recruiting 1, Withdrawn 1
Phase 21Withdrawn 1

Follow MB02: new trials by email Literature Review of MB02 trials Research Report on MB02

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Testing the Addition of ASTX660 (Tolinapant) to the Usual Chemotherapy Treatment (Paclitaxel With or Without Bevacizumab) in Patients With Recurrent Ovarian Cancer
Bevacizumab, Biospecimen Collection, Computed Tomography - Platinum-Refractory Fallopian Tube Carcinoma, Platinum-Refractory Ovarian Carcinoma
Phase 1 / Phase 2WithdrawnNational Cancer Institute (NCI)2025-10-312025-06-03
Clinical Trial of an Anti-cancer Drug, CA-4948 (Emavusertib), in Combination With Chemotherapy Treatment (FOLFOX Plus Bevacizumab) in Metastatic Colorectal Cancer
Bevacizumab, Biopsy Procedure, Biospecimen Collection - Metastatic Colorectal Adenocarcinoma, Stage III Colorectal Cancer AJCC v8
Phase 1RecruitingNational Cancer Institute (NCI)242025-06-232026-09-09
A Pharmacokinetic Study Comparing MB02 And US And EU AvastinĀ® In Healthy Male Volunteers
MB02, US licenced AvastinĀ®, EU approved AvastinĀ® - Healthy Volunteers
Phase 1CompletedmAbxience Research S.L.1142017-12-072021-03-23
TORC1/2 Inhibitor MLN0128 and Bevacizumab in Treating Patients With Recurrent Glioblastoma or Advanced Solid Tumors
Bevacizumab, Laboratory Biomarker Analysis, Pharmacological Study - Adult Glioblastoma, Endometrial Clear Cell Adenocarcinoma
Phase 1Active not recruitingNational Cancer Institute (NCI)502014-05-202026-08-28

Conditions studied

Colorectal Neoplasms (1)  ·  Fallopian Tube Neoplasms (1)  ·  Glioblastoma (1)  ·  Ovarian Neoplasms (1)

Sponsors

National Cancer Institute (NCI) (3)  ·  mAbxience Research S.L. (1)

Countries

United States (2)  ·  United Kingdom (1)

Top investigators

Kristen P Zeligs (1)  ·  Lakshmi Nayak (1)  ·  Muna Albayaty, MBChB,FFPM,MSc (1)  ·  Sunu Valasseri, MBBS, MSc (1)  ·  Susanna V Ulahannan (1)

NIH funding

P30CA006516 (1), U01CA062490 (1), U01CA076576 (1), U10CA180868 (1), UM1CA186689 (1), UM1CA186709 (1), UM1CA186712 (1)